Sudarshan Pharma

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE00TV01023
  • NSEID:
  • BSEID: 543828
INR
36.94
-0.95 (-2.51%)
BSENSE

Jun 18

BSE+NSE Vol: 584000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003813,
    "name": "Sudarshan Pharma",
    "stock_name": "Sudarshan Pharma",
    "full_name": "Sudarshan Pharma Industries Ltd",
    "name_url": "stocks-analysis/sudarshan-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "36.94",
    "chg": -0.95,
    "chgp": "-2.51%",
    "dir": -1,
    "prev_price": "37.89",
    "mcapval": "890.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543828,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE00TV01023",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": 584000,
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sudarshan Pharma Industries Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4002225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SudarshanPharma_technicaldot_4002225.png",
        "date": "2026-05-21 08:04:28",
        "description": "Sudarshan Pharma Industries Ltd has demonstrated a marked shift in price momentum, supported by a suite of bullish technical indicators. The micro-cap specialty chemicals company’s shares surged 5.00% on 21 May 2026, closing at ₹32.57, signalling renewed investor confidence and an upgrade in its technical outlook from mildly bullish to bullish."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Falls 2.23%: 4 Key Factors Driving the Weekly Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-falls-223-4-key-factors-driving-the-weekly-shift-3982988",
        "imagepath": "",
        "date": "2026-05-09 11:01:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Technical momentum shifts to mildly bullish amid sector rally</p>\n                    <p><strong>5 May:</strong> Bullish momentum confirmed with technical upgrades and price rise to Rs.31.00</p>\n                    <p><strong>6 May:</strong> MarketsMOJO upgrades rating to Buy following strong financial performance</p>\n                    <p><strong>7 May:</strong> Technical momentum moderates to mildly bullish amid mixed signals</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.30.30, down 2.23% for the week versus Sensex +1.25%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div cla..."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Forms Golden Cross Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3970691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SudarshanPharma_goldencross_3970691.png",
        "date": "2026-04-30 18:00:24",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Sudarshan Pharma Industries Ltd, signalling a golden cross on 30 Apr 2026. Yet, the broader technical picture is nuanced, with monthly indicators showing mild bearishness and the stock’s recent price action reflecting a more complex momentum story."
      },
      {
        "title": "When is the next results date for Sudarshan Pharma Industries Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sudarshan-pharma-industries-ltd-3967249",
        "imagepath": "",
        "date": "2026-04-28 23:16:38",
        "description": "The next results date for Sudarshan Pharma Industries Ltd is scheduled for April 30, 2026...."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3959099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SudarshanPharma_mojoScore_3959099.png",
        "date": "2026-04-23 10:10:04",
        "description": "Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3943525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SudarshanPharma_mojoScore_3943525.png",
        "date": "2026-04-12 10:10:02",
        "description": "Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-technical-momentum-shifts-amid-mixed-market-signals-3936488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SudarshanPharma_technicaldot_3936488.png",
        "date": "2026-04-08 08:04:04",
        "description": "Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Despite a strong day gain of 4.69%, the stock’s technical indicators present a mixed picture, reflecting both cautious optimism and lingering bearish undertones. This analysis delves into the recent price action, key technical signals, and comparative performance against the broader market."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3928477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SudarshanPharma_mojoScore_3928477.png",
        "date": "2026-04-01 10:10:03",
        "description": "Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 01 April 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-sell-3905012",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SudarshanPharma_mojoScore_3905012.png",
        "date": "2026-03-21 10:10:03",
        "description": "Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date analysis of the company’s standing."
      }
    ],
    "total": 15,
    "sid": "1003813",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sudarshan-pharma-industries-1003813"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday 18Th June 2026",
      "datetime": "15-Jun-2026",
      "details": "Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 inter alia to consider and approve proposal for raising of funds by way of issue of one or more instruments through private placement / preferential issue or such method or combination thereof subject to statutory / regulatory approvals as may be necessary.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "12-Jun-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 the Warrants Committee of the Board of Directors of the Company have at their meeting held today 12/June/2026 considered and approved the allotment of 9000000 equity shares of Re.1/- each consequent upon conversion of 900000 warrants to persons belonging to Promoter Category on a preferential basis as per details given in Annexure I. The disclosures required under Regulation 30 read with Schedule III of SEBI Listing Regulations read with SEBI Master Circular dated 11/Nov/2024 are provided in Annexure II.",
      "source": "BSE"
    },
    {
      "caption": "Meeting Of Warrants Committee Of The Company Scheduled On Thursday 11/June/2026 Now Postponed To Friday 12/June/2026",
      "datetime": "11-Jun-2026",
      "details": "We wish to inform you that the meeting of the Warrants Committee of the Company originally scheduled on 11/June/2026 has been postponed and will now be held on Friday 12/June/2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(18 Jun 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23",
          "dt": "2023-08-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday 18Th June 2026

15-Jun-2026 | Source : BSE

Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 inter alia to consider and approve proposal for raising of funds by way of issue of one or more instruments through private placement / preferential issue or such method or combination thereof subject to statutory / regulatory approvals as may be necessary.

Announcement under Regulation 30 (LODR)-Allotment

12-Jun-2026 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 the Warrants Committee of the Board of Directors of the Company have at their meeting held today 12/June/2026 considered and approved the allotment of 9000000 equity shares of Re.1/- each consequent upon conversion of 900000 warrants to persons belonging to Promoter Category on a preferential basis as per details given in Annexure I. The disclosures required under Regulation 30 read with Schedule III of SEBI Listing Regulations read with SEBI Master Circular dated 11/Nov/2024 are provided in Annexure II.

Meeting Of Warrants Committee Of The Company Scheduled On Thursday 11/June/2026 Now Postponed To Friday 12/June/2026

11-Jun-2026 | Source : BSE

We wish to inform you that the meeting of the Warrants Committee of the Company originally scheduled on 11/June/2026 has been postponed and will now be held on Friday 12/June/2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(18 Jun 2026)

stock-summary
DIVIDEND

Sudarshan Pharma Industries Ltd has declared 3% dividend, ex-date: 25 Aug 23

stock-summary
SPLITS

Sudarshan Pharma Industries Ltd has announced 1:10 stock split, ex-date: 22 Nov 24

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available